IL6 and COVID-19: For example, Kadambari et al. [31] and Moss et al. [32] proposed that pre-existing cytomegalovirus infection (which approaches 80% in older) is associated with the acceleration of immune senescence and may promote increased inflammation-mediating cytokines, such as IL-6, worsening the clinical outcome of COVID-19 [31].